Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
-
Farxiga DAPA-CKD Phase III trial reduced worsening of kidney function, risk of cardiovascular or renal death in patients with chronic kidney disease, irrespective of underlying cause
-
AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined
-
Tagrisso granted Priority Review in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
Forxiga recommended for approval in the EU by CHMP for heart failure
-
Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD
-
COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials
-
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
-
Farxiga granted Breakthrough Therapy Designation in US for chronic kidney disease
-
Lynparza recommended for approval in the EU by CHMP for BRCA-mutated metastatic castration-resistant prostate cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
